124 participants
Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-07-16
- Start Date:
- 2014-09-30
- Completion:
- 2018-12-31
Conditions
- EGFR Positive Non-small Cell Lung Cancer
- Adenocarcinoma
Interventions
- DRUG
No Results Yet